Biomerica Reports Third Quarter 2024 Financial Results
MS Money Moves
by
1d ago
IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended February 29, 2024. The post Biomerica Reports Third Quarter 2024 Financial Results appeared first on Bio Tech Winners ..read more
Visit website
Notable Labs Reports 2023 Financial Results and Provides a Business Update
MS Money Moves
by
1d ago
FOSTER CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Precision Medicine Platform (PPMP), reported financial results for the year ended December 31, 2023 and provided a business update. The post Notable Labs Reports 2023 Financial Results and Provides a Business Update appeared first on Bio Tech Winners ..read more
Visit website
Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets
MS Money Moves
by
1d ago
MALVERN, Pa., April 12, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder will participate in a fireside chat during the Emerging Growth Virtual Healthcare Equity Conference, presented by Noble Capital Markets, taking place from April 17 – 18, 2024. The post Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented b ..read more
Visit website
BioSenic provides further information on its restructuring plan
MS Money Moves
by
1d ago
  PRESS RELEASE - PRIVILEGED INFORMATION The post BioSenic provides further information on its restructuring plan appeared first on Bio Tech Winners ..read more
Visit website
BioSenic fournit des informations complémentaires sur son plan de restructuration
MS Money Moves
by
1d ago
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE The post BioSenic fournit des informations complémentaires sur son plan de restructuration appeared first on Bio Tech Winners ..read more
Visit website
Skye Bioscience Uplists to The Nasdaq Global Market
MS Money Moves
by
4d ago
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, with an emphasis on obesity and ocular indications, announced today that the Company has received approval to list its common stock on the Nasdaq Global Market® stock exchange ("Nasdaq"). The Company's common stock is expected to commence trading on Nasdaq at the market open on Thursday, April 11th, 2024,  ..read more
Visit website
Recce Pharmaceuticals Provides Business Update
MS Money Moves
by
4d ago
SYDNEY, Australia, April 10, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today provided a business update highlighting various ongoing activities and progress made since the Annual General Meeting held on November 8, 2023. The post Recce Pharmaceuticals Provides Business Update appeared first on Bio Tech Winners ..read more
Visit website
Arcutis Appoints David Topper as Chief Financial Officer
MS Money Moves
by
4d ago
Arcutis today announced that David Topper has been appointed Chief Financial Officer effective April 10, 2024. The post Arcutis Appoints David Topper as Chief Financial Officer appeared first on Bio Tech Winners ..read more
Visit website
Excision BioTherapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
MS Money Moves
by
4d ago
SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, today announced presentation of six abstracts at the ASGCT 2024 Annual Meeting, which is being held from May 7-11, 2024 in Baltimore, Maryland. The presentations are related to new data for the Company’s emerging preclinical programs for herpes simplex virus-1 keratitis (HSV-1 Keratitis) and hepatitis B virus (HBV), as well as an overview of a next generation ..read more
Visit website
Nusano to Present at Jefferies Radiopharma Innovation Summit
MS Money Moves
by
4d ago
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. The post Nusano to Present at Jefferies Radiopharma Innovation Summit appeared first on Bio Tech Winners ..read more
Visit website

Follow MS Money Moves on FeedSpot

Continue with Google
Continue with Apple
OR